| Can quality improvement improve the quality of care? A systematic review of reported effects and methodological rigor in plan-do-study-act projects SV Knudsen, HVB Laursen, SP Johnsen, PD Bartels, LH Ehlers, J Mainz BMC health services research 19, 1-10, 2019 | 179 | 2019 |
| Twenty years with diabetes and amputations: a retrospective population‐based cohort study J Røikjer, MH Jensen, P Vestergaard, AM Sørensen, HVB Laursen, ... Diabetic Medicine 37 (12), 2098-2108, 2020 | 23 | 2020 |
| Glucose-lowering therapy in patients with postpancreatitis diabetes mellitus: a nationwide population-based cohort study R Viggers, MH Jensen, HVB Laursen, AM Drewes, P Vestergaard, ... Diabetes Care 44 (9), 2045-2052, 2021 | 19 | 2021 |
| Age at hip fracture and life expectancy in Denmark–Secular trends over two decades B Abrahamsen, HVB Laursen, MK Skjødt, MH Jensen, P Vestergaard Bone 130, 115083, 2020 | 14 | 2020 |
| Sodium glucose cotransporter-2 inhibitor treatment and the risk of diabetic ketoacidosis in Denmark: A retrospective cohort study of five years of use HVB Laursen, JB Røikjer, J Dal, MH Jensen Current Drug Safety 16 (1), 73-81, 2021 | 7 | 2021 |
| ISQUA17-3217 THERE IS NEED FOR IMPROVEMENT OF QUALITY IMPROVEMENT-A SYSTEMATIC REVIEW OF THE PDSA METHOD IN QI STUDIES SV Knudsen, HVB Laursen, LH Ehlers, J Mainz International Journal for Quality in Health Care 29 (suppl_1), 45-45, 2017 | 6 | 2017 |
| A systematic review of cost-effectiveness studies of newer non-insulin antidiabetic drugs: Trends in decision-analytical models for modelling of type 2 diabetes mellitus HVB Laursen, EP Jørgensen, P Vestergaard, LH Ehlers Pharmacoeconomics 41 (11), 1469-1514, 2023 | 3 | 2023 |
| Can quality improvement improve the quality of care? SV Knudsen, HVB Laursen, LH Ehlers, J Mainz ISQua's International Conference: Learning at the system level to improve …, 2017 | 2 | 2017 |
| EE200 A Systematic Review of Cost-Effectiveness Studies of Newer Non-Insulin Antidiabetic Drugs (NNIADS): Trends in Decision-Analytical Models (DAM) for Modelling of Type 2 … H Laursen, EP Jørgensen, P Vestergaard, LH Ehlers Value in Health 25 (12), S92, 2022 | | 2022 |
| Sodium glucose cotransporter-2 inhibitor treatment and the risk of diabetic ketoacidosis in Denmark: a retrospective cohort study of five years of use HVB Laursen, J Røikjer, J Dal, MH Jensen | | 2020 |
| Sodium glucose transporter-2 inhibitor treatment and the risk of diabetic ketoacidosis in Denmark HVB Laursen, J Røikjer, J Dal, MH Jensen, P Vestergaard Dansk Endokrinologisk Selskabs Årsmøde 2020, 2020 | | 2020 |
| Age at Hip Fracture: Time Trends Over Two Decades in a National Hospital Discharge Register B Abrahamsen, HVB Laursen, MK Skjodt, MH Jensen, P Vestergaard Osteoporosis International 30 (Suppl. 2), S167, 2019 | | 2019 |
| Methodological challenges for the valuation of drug related treatment costs for relapsing haematologic cancer patients HVB Laursen, C Vesteghem, M Sommer, MM Nielsen, K Dybkær, ... Basic & Clinical Pharmacology & Toxicology 123 (Suppl. 1), 9, 2018 | | 2018 |
| Does Quality Improvement improve the Quality of Care? A Systematic Review of the Effect and Methodological Rigor of the Plan-Do-Study-Act (PDSA) Method SV Knudsen, HVB Laursen, LH Ehlers, J Mainz | | 2018 |
| The effect of Solu-Cortef® on Cripto-1 expression and cell proliferation in glioblastoma multiforme HVB Laursen, M Sanden, J Prangsgaard, JM Rimestad | | |
